Central nervous system (CNS) diseases such as Alzheimer s
disease, Parkinson s disease, and amyotrophic lateral sclerosis
affect a large number of populations worldwide for which no
suitable cure is currently available. In addition, stroke,
nanoparticle intoxication, diabetes, hypertension, and
psychostimulant abuse either alone or in combination are capable of
inducing potential brain damage. Thus, there is an urgent need to
expand our knowledge to find suitable therapeutic strategies to
enhance neurorepair processes in such diseases.
This volume presents neuroprotection and novel therapeutic
strategies developed in the last 5 years by 12 world leaders in the
field. The term neuroprotection means rescuing neuronal and
non-neuronal cells together. The cerebral endothelium that
constitutes the anatomical and physiological site of the
blood-brain barrier (BBB) is one of the most important non-neural
cells in the CNS. Any distortion of the BBB leads to brain diseases
and restoration of the barrier results in neuroprotection. Thus,
the BBB appears to be the "gateway" for neurological diseases and
neurorepair. However, to treat brain tumors or infarcts, new
therapeutic strategies are needed to enhance brain drug delivery
using nanotechnology. In addition, apart from conventional drugs,
restoration of BBB function could also be achieved by means of
antibodies directed against specific proteins, neurotransmitters or
exogenous supplement of neurotrophic factors. Since co-morbidity
factors e.g., hypertension, diabetes, and exposure of nanoparticles
could complicate the pathogenesis of neurological disorders either
an enhanced dose of the drug or nanodelivery of a combination of
several drugs is needed to achieve neuroprotection.
This volume of "International Review of Neurobiology" is the
first to discuss novel therapeutic strategies in situations of
neurological disorders in combination with different co-morbidity
factors.
Reviews written by experts in such a way thatprovides basic
knowledge for beginners and advanced information for researchers
and experts.
New aspects of Neurodegenerative diseasessuch as;Alzheimer s
Disease, Parkinson s Disease, Amyotrophic Lateral Sclerosis are
presented with thelatest therapeutic measures.
Exacerbation of brain pathology in hypertension or diabetes is
discussed for the first time.
"
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!